VA - based on Service Treatment Record (STR) | |||||||
Code | Rating | Condition | Code | Rating | Exam | ||
Mild Persistent Asthma | 6602 | 10% | Asthma | 6602 | 10% | STR | |
Migraine Headaches | Cat III | Migraine Headaches | 8100 | 10% | STR | ||
Attention Deficit with Memory Problems | Cat IV | No VA Entry | |||||
Other x 2 | |||||||
Combined: 20% |
UNFITTING CONDITION | VASRD CODE | RATING |
Mild Persistent Asthma | 6602 | 10% |
COMBINED | 10% |
AF | PDBR | CY2009 | PD2009-00104
The CI was referred to the PEB, found unfit for the Asthma condition, determined unfit for continued military service and separated at 10% disability using the Veterans Affairs Schedule for Ratings Disabilities (VASRD) and applicable Air Force and Department of Defense regulations. Other Conditions . There is no evidence that supports finding either migraines or gastroesophageal reflux disease unfit and therefore these conditions are not rated.
AF | PDBR | CY2013 | PD 2013 00179
It is limited to those conditions determined by the PEB to be unfitting for continued military service and those conditions identified but not determined to be unfitting by the PEB when specifically requested by the CI. The Board directs attention to its rating recommendationbased on the above evidence.Both the FPEB and the VA rated asthma condition,under code 6620, asthma, bronchial, IAW §4.97 but at different rating levels; the FPEB rated 10%citing intermittent use of medication; and the...
AF | PDBR | CY2013 | PD2013 00352
SEPARATION DATE: 20050114 It is limited to those conditions determined by the PEB to be unfitting for continued military service and those conditions identified, but not determined to be unfitting by the PEB when specifically requested by the CI. The Board noted that the NARSUM and multiple entries found in the service treatment record, months prior to separation, documented that daily use of inhaled anti-inflammatory medication (Advair, Azmacort or Flovent)and daily inhalational...
AF | PDBR | CY2013 | PD-2013-02236
In December 2004 theMEB found the asthma condition had stabilized sufficiently and the PEB adjudicated “exertion asthma” unfitting, rated at 10% disability and the CI was removed from the TDRL on 30 December 2004. The Board deliberated if the TDRL NARSUM current medications’listing oral Singulair was supported by the record and if it met the VASRD 6602 30% rating criteria for daily oral bronchodilator therapy.The Board discussed the evidence of record concerning Singulair use.Singulair was...
AF | PDBR | CY2011 | PD2011-00898
VASRD §4.97 rating criteria for asthma are based on the number and severity of clinical exacerbations; the type and the frequency of medications used to treat the condition; and PFT values for FEV1 and FEV1/FVC ratio. It is noted that the VA subsumed any asthma rating in the overall OSA rating, although the VA rating decision stated “the examiner did not note any compensable level of disability due to your mild persistent asthma.” After considerable deliberation, members agreed [member...
AF | PDBR | CY2012 | PD2012-00289
The narrative summary (NARSUM), service treatment records (STR), and prior to separation VA C&P examination all indicate that the CI required and used daily inhalational bronchodilator and oral medications which would support a 30% rating IAW VASRD code 6602 (“daily inhalational or oral bronchodilator therapy or inhalational anti-inflammatory medication”) and VASRD §4.97. RECOMMENDATION : The Board recommends that the CI’s prior determination be modified as follows; and, that the discharge...
AF | PDBR | CY2013 | PD2013 00234
The MEB also identified and forwarded one other condition (shrapnel wound to the right upper arm, which met retention standards) to the PEB.The PEBadjudicated “asthma…” rated at 30%and placed the CI on the Temporary Retired Disability List (TDRL) in order for the condition to be stabilized by treatment.The remaining condition was determined to be not unfitting.The CI made no appeals and was placed on the TDRL in November, 2004, where he continued to receive medical treatment. The Board’s...
AF | PDBR | CY2012 | PD2012-00908
The treatment regimens documented in the NARSUM examination reported that the CI was prescribed daily inhaled steroid medication along with a rescue inhaler supporting the 30% rating while the C&P examination noted intermittent bronchodilator supporting the 10% rating. Service Treatment Record Exhibit C. Department of Veterans’ Affairs Treatment Record XX Director Physical Disability Board of Review 2 PD1200908 Minority Opinion. The minority voter concluded the preponderance of evidence of...
AF | PDBR | CY2012 | PD2012 01240
The Board evaluates DVA evidence proximal to separation in arriving at its recommendations, but its authority resides in evaluating the fairness of DES fitness decisions and rating determinations for disability at the time of separation. Asthma Condition .The CI had a history of exercised-induced asthma with running since June 2001 manifested by shortness of breath (SOB), wheezing, and chest discomfort.He reported mild, subjective improvement with an inhaled bronchodilator, which was...
AF | PDBR | CY2014 | PD-2014-00754
SEPARATION DATE: 20060707 It is limited to those conditions determined by the PEB to be unfitting for continued military service and those conditionsidentified, but not determined to be unfitting by the PEB when specifically requested by the CI. The NARSUM attached a medication profile for the CI for the period 21 January 2005 to 1 February 2006, to its report to the PEB.At the VA Compensation and Pension (C&P) dated 12 May 2006 (2 months before separation), the CI wasreported to be taking...